CURRENT ROADSHOW VIDEOS

LATEST NEWS

Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple...

The Phase II Study Will Combine Hemispherx’s Ampligen with Keytruda OCALA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an...

Citius Licenses Mino-Wrap From MD Anderson Cancer Center

- New technology designed to reduce infections after implantation of devices - First target is breast tissue expanders - Intended for minimizing serious complications of post-operative...
Advertisement

CEOLIVE INTERVIEWS

Precision Therapeutics (AIPT) Bringing AI to Precision Medicine

In this episode of CEOLIVE.TV we are joined by Richard Gabriel, COO of TumorGenesis, a wholly owned subsidiary of Precision Therapeutics, ticker AIPT. About Precision...

Social Life Network (WDLF) Capitalizing on New Trend for Niche Interest...

In this episode, we’re joined by Ken Tapp, CEO of Social Life Network, a cloud-based social media and social network technology company based in Denver, Colorado...